Army of Thieves
2021
Search results
Jul 24, 2024 · Christian Angermayer invests in life sciences, fintech, AI, psychedelics and cryptocurrencies through his family office Apeiron Investment Group. He made his first millions cofounding biotech...
1 day ago · Christian Angermayer is seemingly behind every flashy investment of the last decade. With boundless bravado and a roster of famous friends—including Peter Thiel, Uma Thurman, and the president ...
I am dedicated to fighting the global mental health crisis, both through atai Life Sciences, as well as through the mental health non-profit, Aurora.
Christian Angermayer is a serial entrepreneur, investor, and founder of Apeiron Investment Group. Christian is the driving force behind the current renaissance of psychedelics - and the development of psilocybin and DMT as potential treatments for a wide range of mental health conditions.
Apeiron Investment Group is the private investment firm of entrepreneur and investor Christian Angermayer. We are global investors in the most exciting and world-changing tech & biotech companies with a hands-on, entrepreneurial approach.
Christian Angermayer, a 39-year-old investor, in 1999 quit school to help found a biotech company that would eventually become Alnylam. When he sold the company, Angermayer...
Sep 15, 2021 · Christian Angermayer dropped out of college at 21 to co-found a biotech firm now worth $23 billion. The 43-year-old German billionaire runs his $3.5 billion family office Apeiron...
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office, Apeiron Investment Group. With more than US$ 2.5 billion under management and 50 people across six international locations, Apeiron Investment Group focuses on Life Sciences, FinTech & Crypto, and Future Tech, and ...
Christian Angermayer is the Chairman and Co-Founder of Cambrian Bio. A serial entrepreneur and investor, Christian has raised over $1.6B for his portfolio companies. He was co-founder of Ribopharma, a German biotech company pioneering RNAi (today Alnylam, $9B market cap).
Christian Angermayer is a serial entrepreneur and investor who builds and invests in companies shaping the Next Human Agenda: a future in which technology empowers people to live longer, healthier, and happier lives.
